2020 — cTBS of DLPFC and emotion recognition

Population and APD classification

N = 93 healthy young adults. The ASRI-4 was used to measure APD symptoms before stimulation. The authors explicitly state that the scale did not establish clinical diagnosis.

A sample-relative median split produced:

  • High APD: N = 38, M = 3.06, SD = 1.35
  • Low APD: N = 55, M = 0.34, SD = 0.48

APD symptoms therefore function as a subgroup/moderator variable, not a treatment endpoint.

Intervention

Participants received one 40-second session of real or sham cTBS over the left or right DLPFC.

Outcome

After stimulation participants completed a dynamic face-recognition task involving happy, fearful, painful, and sad expressions.

Direct finding

Real DLPFC stimulation improved recognition of selected emotions relative to sham. The significant emotion-recognition differences were concentrated in the high-APD-symptom group. Left stimulation was associated with better recognition of happy, painful, and sad expressions in this group; right stimulation showed a happy-expression effect.

Why it matters

The program crosses an inference gate from observational neural/cognitive associations to experimental manipulation of a neural target and a proximal emotional-processing outcome.

Critical limitations

  • no baseline emotion-recognition measurement;
  • APD groups were created from a median split, not a diagnostic threshold;
  • participants did not have diagnosed APD;
  • APD symptoms were not remeasured after stimulation;
  • no aggression/antisocial-behavior outcome;
  • single-session acute experiment;
  • no follow-up;
  • no demonstrated mediation from emotion recognition to later antisocial symptom change.

Inference boundary

This study supports:

cTBS can acutely alter emotion-recognition performance, especially among participants elevated on self-reported APD symptoms.

It does not support:

cTBS reduced APD/ASPD symptoms.

See Audit-Brain-Stimulation-ASPD-v0.3.7.

Built with LogoFlowershow